CalciMedica, Inc.
CALCHealthcare|Biotechnology|US
$1.36
+0.06 (+4.62%)
DCF Value
$0.00
Tangible Book / Share
$1.61
Cash / Share
$5.44
Ownership Breakdown
109.8%
Float
3.1M
Shares Outstanding
3.5M
Float Shares
Major Holders (40)
Combined: 301.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Christopher D. Alafi | Individual | 19.90% | 7,220,101 | Aug 24, 2026 | 13D/G |
| Alafi Capital Company LLC | Other | 19.90% | 7,220,101 | Aug 24, 2026 | 13D/G |
| Fred A. Middleton | Individual | 18.30% | 2,550,550 | Nov 26, 2024 | 13D/G |
| Timothy C. Mills | Partnership | 17.90% | 2,481,567 | Nov 26, 2024 | 13D/G |
| Alafi Capital Company, LLC | Other | 11.30% | 1,583,153 | Aug 5, 2025 | 13D/G |
| Bering Partners II GP, L.L.C. | Other | 9.99% | 3,553,398 | Aug 21, 2026 | 13D/G |
| Philip M Sawyer | Individual | 9.99% | 3,553,398 | Aug 21, 2026 | 13D/G |
| Evgeny Zaytsev | Individual | 9.99% | 3,553,398 | Aug 21, 2026 | 13D/G |
| Bering Partners II, L.P. | Partnership | 9.99% | 3,553,398 | Aug 21, 2026 | 13D/G |
| Steven Boyd | HC, IN | 9.99% | 3,411,361 | Aug 14, 2026 | 13D/G |
| Armistice Capital, LLC | IA, OO | 9.99% | 3,411,361 | Aug 14, 2026 | 13D/G |
| Woodline Partners LP | IA, PN | 8.10% | 2,489,729 | Aug 14, 2026 | 13D/G |
| Sanderling Ventures Partners VI, L.P. | Partnership | 7.10% | 968,640 | Nov 26, 2024 | 13D/G |
| Eric W. Roberts | Individual | 6.40% | 1,965,916 | Jun 30, 2026 | 13D/G |
| A. Rachel Leheny | IA, IN | 6.30% | 1,926,347 | Jun 30, 2026 | 13D/G |
| Sanderling Venture Partners VI Co-Investment Fund, L.P. | Partnership | 6.20% | 838,465 | Nov 26, 2024 | 13D/G |
| Jon M. Plexico | HC, IN | 6.00% | 2,149,522 | Aug 25, 2026 | 13D/G |
| Stonepine Capital Management, LLC | IA, OO | 6.00% | 2,149,522 | Aug 25, 2026 | 13D/G |
| Stonepine Capital, L.P. | Partnership | 6.00% | 2,149,522 | Aug 25, 2026 | 13D/G |
| Stonepine GP, LLC | Other | 6.00% | 2,149,522 | Aug 25, 2026 | 13D/G |
| Bering Partners II GP, L.L.C. ("Bering II GP") | Other | 5.80% | 663,246 | Oct 29, 2025 | 13D/G |
| Philip Sawyer ("Sawyer") | Individual | 5.80% | 663,246 | Oct 29, 2025 | 13D/G |
| Evgeny Zaytsev ("Zaytsev") | Individual | 5.80% | 663,246 | Oct 29, 2025 | 13D/G |
| Bering Partners II, L.P. ("Bering II") | Partnership | 5.80% | 663,246 | Oct 29, 2025 | 13D/G |
| Heights Capital Management, Inc. | Corporation | 5.10% | 1,556,081 | Jul 20, 2026 | 13D/G |
| CVI Investments, Inc. | Corporation | 5.10% | 1,556,081 | Jul 20, 2026 | 13D/G |
| Avenue Venture Opportunities Partners II, LLC | Other | 4.99% | 4,641,163 | Jun 25, 2026 | 13D/G |
| Marc Lasry | Individual | 4.99% | 4,641,163 | Jun 25, 2026 | 13D/G |
| GL Venture Opportunities Partners II, LLC | Other | 4.99% | 4,641,163 | Jun 25, 2026 | 13D/G |
| Avenue Capital Management II, L.P. | Investment adviser | 4.99% | 4,641,163 | Jun 25, 2026 | 13D/G |
| Avenue Venture Opportunities Fund II, L.P. | Other | 4.99% | 4,641,163 | Jun 25, 2026 | 13D/G |
| Laurence W. Lytton | Individual | 4.40% | 468,943 | Nov 14, 2024 | 13D/G |
| Deerfield Mgmt, L.P. | Partnership | 4.34% | 653,253 | Feb 6, 2026 | 13D/G |
| Deerfield Management Company, L.P. | Partnership | 4.34% | 653,253 | Feb 6, 2026 | 13D/G |
| Deerfield Partners, L.P. | Partnership | 4.34% | 653,253 | Feb 6, 2026 | 13D/G |
| James E. Flynn | Individual | 4.34% | 653,253 | Feb 6, 2026 | 13D/G |
| Dr. Andrew Schiff | Individual | 3.90% | 781,671 | Mar 3, 2025 | 13D/G |
| Aisling Capital Partners V LLC | Other | 3.90% | 781,671 | Mar 3, 2025 | 13D/G |
| Aisling Capital Partners V, LP | Partnership | 3.90% | 781,671 | Mar 3, 2025 | 13D/G |
| Aisling Capital V, LP | Partnership | 3.90% | 781,671 | Mar 3, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 16,510,522 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Roberts Eric W | director, officer: CHIEF BUSINESS OFFICER | Nov 3, 2026 | AWARD | 180,000 | $1.47 | $264.6K | Form 4 |
| Glicklich Alan | director | Oct 1, 2026 | AWARD | 20,000 | $1.64 | $32.8K | Form 4 |
| Zaytsev Evgeny | director | Oct 1, 2026 | AWARD | 20,000 | $1.64 | $32.8K | Form 4 |
| Guerard Frederic | director | Oct 1, 2026 | AWARD | 20,000 | $1.64 | $32.8K | Form 4 |
| Shaw Allan | director | Oct 1, 2026 | AWARD | 20,000 | $1.64 | $32.8K | Form 4 |
| WILSON ROBERT N | director | Oct 1, 2026 | AWARD | 20,000 | $1.64 | $32.8K | Form 4 |
| Hebbar Sudarshan | Chief Medical Officer | Sep 24, 2026 | AWARD | 180,000 | $1.74 | $313.2K | Form 4 |
| Stauderman Kenneth A. | Chief Scientific Officer | Sep 24, 2026 | AWARD | 180,000 | $1.74 | $313.2K | Form 4 |
| Bardin Stephen | Chief Financial Officer | Sep 24, 2026 | AWARD | 190,000 | $1.74 | $330.6K | Form 4 |
| Leheny A. Rachel | director, officer: CHIEF EXECUTIVE OFFICER | Sep 24, 2026 | AWARD | 360,000 | $1.74 | $626.4K | Form 4 |
| ALAFI CAPITAL CO LLC | 10 percent owner | Aug 19, 2026 | AWARD | 3,529,192 | $0.80 | $2.8M | Form 4 |
| ALAFI CAPITAL CO LLC | 10 percent owner | Aug 19, 2026 | AWARD | 3,529,192 | $1.00 | $3.5M | Form 4 |
| Shaw Allan | director | Aug 19, 2026 | AWARD | 10,000 | $0.61 | $6.1K | Form 4 |
| Glicklich Alan | director | Aug 19, 2026 | AWARD | 10,000 | $0.61 | $6.1K | Form 4 |
| Guerard Frederic | director | Aug 19, 2026 | AWARD | 10,000 | $0.61 | $6.1K | Form 4 |
| Zaytsev Evgeny | director | Aug 19, 2026 | AWARD | 1,450,267 | $0.80 | $1.2M | Form 4 |
| Zaytsev Evgeny | director | Aug 19, 2026 | AWARD | 1,450,267 | $1.00 | $1.5M | Form 4 |
| Zaytsev Evgeny | director | Aug 19, 2026 | AWARD | 10,000 | $0.61 | $6.1K | Form 4 |
| WILSON ROBERT N | director | Aug 19, 2026 | AWARD | 1,182,621 | $0.80 | $950.0K | Form 4 |
| WILSON ROBERT N | director | Aug 19, 2026 | AWARD | 1,182,621 | $1.00 | $1.2M | Form 4 |
| WILSON ROBERT N | director | Aug 19, 2026 | AWARD | 10,000 | $0.61 | $6.1K | Form 4 |
| Hebbar Sudarshan | Chief Medical Officer | Aug 19, 2026 | AWARD | 124,486 | $0.80 | $100.0K | Form 4 |
| Hebbar Sudarshan | Chief Medical Officer | Aug 19, 2026 | AWARD | 124,486 | $1.00 | $124.5K | Form 4 |
| Roberts Eric W | director, officer: CHIEF BUSINESS OFFICER | Aug 19, 2026 | AWARD | 186,729 | $0.80 | $150.0K | Form 4 |
| Roberts Eric W | director, officer: CHIEF BUSINESS OFFICER | Aug 19, 2026 | AWARD | 186,729 | $1.00 | $186.7K | Form 4 |
| Leheny A. Rachel | director, officer: CHIEF EXECUTIVE OFFICER | Aug 19, 2026 | AWARD | 186,729 | $0.80 | $150.0K | Form 4 |
| Leheny A. Rachel | director, officer: CHIEF EXECUTIVE OFFICER | Aug 19, 2026 | AWARD | 186,729 | $1.00 | $186.7K | Form 4 |
| ALAFI CAPITAL CO LLC | 10 percent owner | Jun 25, 2026 | OTHER | 0 | — | — | Form 4 |
| ALAFI CAPITAL CO LLC | 10 percent owner | Jun 25, 2026 | OTHER | 130,651 | $7.15 | $934.2K | Form 4 |
| Zaytsev Evgeny | director | Jul 2, 2026 | AWARD | 20,000 | $0.97 | $19.3K | Form 4 |
| Zaytsev Evgeny | director | Jul 2, 2026 | OTHER | 0 | — | — | Form 4 |
| Zaytsev Evgeny | director | Jan 23, 2024 | OTHER | 130,651 | $7.15 | $934.2K | Form 4 |
| Middleton Fred A | director, 10 percent owner: | Jun 25, 2026 | BUY | 248,972 | $0.80 | $200.0K | Form 4 |
| Hebbar Sudarshan | Chief Medical Officer | Jun 25, 2026 | AWARD | 124,486 | $0.80 | $100.0K | Form 4 |
| WILSON ROBERT N | director | Jun 25, 2026 | AWARD | 1,182,621 | $0.80 | $950.0K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Jun 25, 2026 | AWARD | 186,729 | $0.80 | $150.0K | Form 4 |
| Leheny A. Rachel | director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER | Jun 25, 2026 | AWARD | 186,729 | $0.80 | $150.0K | Form 4 |
| Bardin Stephen | Chief Financial Officer | Apr 5, 2025 | AWARD | 67,728 | $0.58 | $39.6K | Form 4 |
| Hebbar Sudarshan | Chief Medical Officer | Apr 5, 2025 | AWARD | 91,173 | $0.58 | $53.3K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Apr 5, 2025 | AWARD | 83,358 | $0.58 | $48.8K | Form 4 |
| Dunn Michael J. | President and COO | Apr 5, 2025 | AWARD | 65,124 | $0.58 | $38.1K | Form 4 |
| Stauderman Kenneth A. | Chief Scientific Officer | Apr 5, 2025 | AWARD | 65,124 | $0.58 | $38.1K | Form 4 |
| Leheny A. Rachel | director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER | Apr 5, 2025 | AWARD | 148,482 | $0.58 | $86.9K | Form 4 |
| Glicklich Alan | director | Oct 13, 2025 | AWARD | 937 | $3.26 | $3.1K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Sep 18, 2025 | BUY | 2,500 | $3.07 | $7.7K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Sep 15, 2025 | BUY | 3,400 | $2.68 | $9.1K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Sep 12, 2025 | BUY | 5,000 | $3.12 | $15.6K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Sep 9, 2025 | BUY | 2,343 | $3.15 | $7.4K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Aug 29, 2025 | BUY | 800 | $2.74 | $2.2K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Aug 28, 2025 | BUY | 9,200 | $2.86 | $26.3K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Aug 21, 2025 | BUY | 3,508 | $2.79 | $9.8K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Aug 20, 2025 | OPTION EX. | 15,000 | $1.53 | $22.9K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Aug 20, 2025 | OPTION EX. | 15,000 | $1.53 | $22.9K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Aug 20, 2025 | BUY | 2,000 | $2.72 | $5.4K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Aug 19, 2025 | BUY | 1,000 | $2.79 | $2.8K | Form 4 |
| Hebbar Sudarshan | Chief Medical Officer | Aug 19, 2025 | BUY | 9,563 | $2.82 | $27.0K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Aug 15, 2025 | BUY | 5,076 | $2.90 | $14.7K | Form 4 |
| Hebbar Sudarshan | Chief Medical Officer | Aug 15, 2025 | BUY | 4,392 | $2.79 | $12.3K | Form 4 |
| Hebbar Sudarshan | Chief Medical Officer | Aug 14, 2025 | BUY | 1,584 | $2.58 | $4.1K | Form 4 |
| Stauderman Kenneth A. | Chief Scientific Officer | Jul 28, 2025 | BUY | 1,000 | $3.96 | $4.0K | Form 4 |
| Stauderman Kenneth A. | Chief Scientific Officer | Jul 25, 2025 | SELL | 1,000 | $3.65 | $3.6K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Jul 22, 2025 | BUY | 1,500 | $3.77 | $5.7K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Jul 21, 2025 | BUY | 1,500 | $3.37 | $5.1K | Form 4 |
| Leheny A. Rachel | director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER | Jul 21, 2025 | BUY | 1,000 | $3.40 | $3.4K | Form 4 |
| WILSON ROBERT N | director | Jul 18, 2025 | BUY | 4,500 | $2.87 | $12.9K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Jul 18, 2025 | BUY | 2,000 | $2.88 | $5.8K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Jul 14, 2025 | BUY | 6,500 | $2.43 | $15.8K | Form 4 |
| Leheny A. Rachel | director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER | Jul 14, 2025 | BUY | 2,500 | $2.47 | $6.2K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Jul 9, 2025 | BUY | 5,000 | $1.60 | $8.0K | Form 4 |
| Stauderman Kenneth A. | Chief Scientific Officer | Jul 1, 2025 | BUY | 1,000 | $1.85 | $1.9K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Jun 26, 2025 | BUY | 4,500 | $1.44 | $6.5K | Form 4 |
| Hebbar Sudarshan | Chief Medical Officer | Jun 24, 2025 | AWARD | 83,300 | $1.53 | $127.4K | Form 4 |
| Bardin Stephen | Chief Financial Officer | Jun 24, 2025 | AWARD | 20,000 | $1.53 | $30.6K | Form 4 |
| Bardin Stephen | Chief Financial Officer | Jun 26, 2025 | BUY | 2,000 | $1.50 | $3.0K | Form 4 |
| Stauderman Kenneth A. | Chief Scientific Officer | Jun 24, 2025 | AWARD | 47,125 | $1.53 | $72.1K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Jun 24, 2025 | AWARD | 72,750 | $1.53 | $111.3K | Form 4 |
| Dunn Michael J. | President and COO | Jun 24, 2025 | AWARD | 47,125 | $1.53 | $72.1K | Form 4 |
| Leheny A. Rachel | director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER | Jun 24, 2025 | AWARD | 77,625 | $1.53 | $118.8K | Form 4 |
| Guerard Frederic | director | Jun 24, 2025 | AWARD | 15,000 | $1.53 | $22.9K | Form 4 |
| Guerard Frederic | director | Jun 24, 2025 | AWARD | 10,000 | $1.53 | $15.3K | Form 4 |
| Guerard Frederic | director | Jun 24, 2025 | AWARD | 10,000 | $1.65 | $16.5K | Form 4 |
| Guerard Frederic | director | Jun 24, 2025 | AWARD | 5,000 | $1.53 | $7.7K | Form 4 |
| Glicklich Alan | director | Jun 24, 2025 | AWARD | 15,000 | $1.53 | $22.9K | Form 4 |
| Glicklich Alan | director | Jun 24, 2025 | AWARD | 10,000 | $1.65 | $16.5K | Form 4 |
| Glicklich Alan | director | Jun 24, 2025 | AWARD | 10,000 | $1.53 | $15.3K | Form 4 |
| Glicklich Alan | director | Jun 24, 2025 | AWARD | 4,166 | $1.53 | $6.4K | Form 4 |
| Shaw Allan | director | Jun 24, 2025 | AWARD | 26,250 | $1.53 | $40.2K | Form 4 |
| Shaw Allan | director | Jun 24, 2025 | AWARD | 10,000 | $1.53 | $15.3K | Form 4 |
| Shaw Allan | director | Jun 24, 2025 | AWARD | 10,000 | $1.65 | $16.5K | Form 4 |
| Shaw Allan | director | Jun 24, 2025 | AWARD | 8,594 | $1.53 | $13.1K | Form 4 |
| WILSON ROBERT N | director | Jun 24, 2025 | AWARD | 36,562 | $1.53 | $55.9K | Form 4 |
| WILSON ROBERT N | director | Jun 24, 2025 | AWARD | 12,031 | $1.53 | $18.4K | Form 4 |
| WILSON ROBERT N | director | Jun 24, 2025 | AWARD | 10,000 | $1.53 | $15.3K | Form 4 |
| WILSON ROBERT N | director | Jun 24, 2025 | AWARD | 10,000 | $1.65 | $16.5K | Form 4 |
| MIDDLETON FRED A | director, 10 percent owner: | Jun 24, 2025 | AWARD | 19,687 | $1.53 | $30.1K | Form 4 |
| MIDDLETON FRED A | director, 10 percent owner: | Jun 24, 2025 | AWARD | 10,000 | $1.53 | $15.3K | Form 4 |
| MIDDLETON FRED A | director, 10 percent owner: | Jun 24, 2025 | AWARD | 10,000 | $1.65 | $16.5K | Form 4 |
| MIDDLETON FRED A | director, 10 percent owner: | Jun 24, 2025 | AWARD | 6,562 | $1.53 | $10.0K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Jun 11, 2025 | BUY | 5,000 | $1.85 | $9.3K | Form 4 |
| Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | Jun 6, 2025 | BUY | 5,000 | $1.77 | $8.9K | Form 4 |